626 Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Sell
1,967
-33
-2% -$33.7K 0.92% 22
2026
Q1
$1.84M Sell
2,000
-70
-3% -$71K 0.82% 22
2025
Q4
$2.22M Sell
2,070
-200
-9% -$191K 0.96% 19
2025
Q3
$1.73M Sell
2,270
-23
-1% -$17.1K 0.76% 21
2025
Q2
$1.79M Hold
2,293
0.84% 20
2025
Q1
$1.89M Sell
2,293
-11
-0.5% -$9.15K 0.97% 19
2024
Q4
$1.78M Hold
2,304
0.96% 20
2024
Q3
$2.04M Hold
2,304
1.13% 20
2024
Q2
$2.09M Sell
2,304
-20
-0.9% -$16K 1.21% 18
2024
Q1
$1.81M Sell
2,324
-2
-0.1% -$1.42K 1.09% 17
2023
Q4
$1.36M Sell
2,326
-100
-4% -$58.4K 0.9% 22
2023
Q3
$1.3M Hold
2,426
0.88% 22
2023
Q2
$1.14M Sell
2,426
-50
-2% -$21K 0.73% 29
2023
Q1
$850K Hold
2,476
0.56% 37
2022
Q4
$906K Sell
2,476
-150
-6% -$53.2K 0.63% 39
2022
Q3
$849K Hold
2,626
0.69% 34
2022
Q2
$851K Buy
2,626
+184
+8% +$55.2K 0.65% 33
2022
Q1
$699K Sell
2,442
-324
-12% -$83.4K 0.45% 45
2021
Q4
$764K Buy
+2,766
New +$701K 0.47% 42
2021
Q1
$699K Buy
+2,442
New +$478K 0.45% 45

Other funds holding LLY

626 Financial's LLY Position: Q2 2026 in Review

626 Financial reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2026, selling an estimated $33.7K and leaving 1,967 shares worth $2.36M. The position accounts for 0.92% of the portfolio, ranked #22.

626 Financial first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. 2,962 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 626 Financial held 1,967 shares of Eli Lilly worth $2.36M as of Q2 2026.
  • 626 Financial sold 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
  • Eli Lilly made up 0.92% of 626 Financial's portfolio in Q2 2026, its #22 holding.
  • 626 Financial first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
  • 2,962 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 626 Financial's 13F filing for Q2 2026, filed 27 Jul 2026.